FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space
The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last…
17/06/2021 - 6 minutes
Biogen
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
27/04/2021 - 6 minutes
Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III
Hopes of seeing an approved treatment for the inflammatory bowel condition pouchitis have been dashed…
01/08/2019 - 2 minutes
Biogen Acquires UK Biotech Developing Gene Therapy for Blindness
The big US biotech Biogen has agreed to acquire Nightstar Therapeutics for €773M ($877M), including…
04/03/2019 - 2 minutes
Swiss Genomics Firm, Biogen and Microsoft Team Up to Treat Multiple Sclerosis
BC Platforms and Microsoft will be working with Biogen and the Accelerated Cure Project to…
16/10/2017 - 3 minutes
How Close Are We to Curing ALS? A Review of Biotech’s Efforts
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug…
03/10/2017 - 8 minutes
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
12/06/2017 - 3 minutes
How Biotech is Mastering Multiple Sclerosis: A Review
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis.…
25/04/2017 - 7 minutes
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s…
19/12/2016 - 7 minutes
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who…
30/09/2016 - 1 minute
Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU
Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy…
17/05/2016 - 2 minutes
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Back in 2011, France's biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more…
11/02/2016 - 3 minutes
